ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy
Chenran Wang, Maohua Huang, Yuning Lin, Yiming Zhang, Jinghua Pan, Chang Jiang, Min-Jing Cheng, Shenrong Li, Wenzhuo He, Zhengqiu Li, Zhengchao Tu, Jun Fan, Hu-Hu Zeng, Jiahui Lin, Yongjin Wang, Nan Yao, Tongzheng Liu, Qi Qi, Xiangning Liu, Zhimin Zhang, Minfeng Chen, Liangping Xia, Dongmei Zhang, Wen‐Cai Ye
Topics & Concepts
Cancer researchHDAC1Colorectal cancerHistone deacetylaseAcetylationBiologyCancerPharmacologyMedicineHistoneInternal medicineBiochemistryGeneHistone Deacetylase Inhibitors ResearchSignaling Pathways in DiseaseEpigenetics and DNA Methylation